Evidence map›Paper›PMID 31288367›Full record

ArticleThe Journal of thoracic and cardiovascular surgery2019

A novel mechanism for immune regulation after human lung transplantation.

Thalachallour Mohanakumar, Monal Sharma, Sandhya Bansal, Ranjithkumar Ravichandran, Michael A Smith, Ross M Bremner

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in The Journal of thoracic and cardiovascular surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  10. Review
  11. A decline in club cell secretory proteins in lung transplantation is associated with release of natural killer cells exosomes leading to chronic rejection.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Article
  12. Review
  13. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Observational
  14. Review
  15. Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2020
    Article
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Thalachallour MohanakumarNorton Thoracic Institute, St Joseph's Hospital and Medical Center, Phoenix, Ariz. Electronic address: Tm.kumar@dignityhealth.org.
Monal SharmaNorton Thoracic Institute, St Joseph's Hospital and Medical Center, Phoenix, Ariz.
Sandhya BansalNorton Thoracic Institute, St Joseph's Hospital and Medical Center, Phoenix, Ariz.
Ranjithkumar RavichandranNorton Thoracic Institute, St Joseph's Hospital and Medical Center, Phoenix, Ariz.
Michael A SmithNorton Thoracic Institute, St Joseph's Hospital and Medical Center, Phoenix, Ariz.
Ross M BremnerNorton Thoracic Institute, St Joseph's Hospital and Medical Center, Phoenix, Ariz.
St. Joseph's Hospital and Medical Center · US

Funding

IMMUNE MECHANISMS OF REJECTION IN HUMAN LUNG ALLOGRAFTSR01HL056643 · NHLBI · WASHINGTON UNIVERSITY · PI MOHANAKUMAR, THALACHALLOUR · 1996 to 2015
$6.5M
ALLOANTIBODIES TO MHC INDUCES AUTOIMMUNITY AND OBLITERATIVE AIRWAY DISEASE (OAD)R01HL092514 · NHLBI · WASHINGTON UNIVERSITY · PI MOHANAKUMAR, THALACHALLOUR · 2009 to 2018
$3.0M
EXOSOMES: ROLE IN ALLOGRAFT REJECTION AND POTENTIAL AS A BIOMARKERR21AI123034 · NIAID · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI MOHANAKUMAR, THALACHALLOUR · 2016 to 2017
$397k
NHLBI NIH HHS R01 HL056643NHLBI NIH HHS R01 HL092514NIAID NIH HHS R21 AI123034
6 · The paper itself

Abstract

objectiveLung transplantation is therapeutic for end-stage lung disease, but survival is limited due to bronchiolitis obliterans syndrome and restrictive chronic lung allograft dysfunction. We sought a common denominator in lung transplant recipients, analyzing risk factors that trigger immune responses that lead to bronchiolitis obliterans syndrome.

methodsWe collected blood from patients who underwent lung transplant at our institution. Exosomes were isolated from the sera of recipients with risk factors for chronic rejection and from stable recipients. Exosomes were analyzed with western blot, using antibodies to lung self-antigens K alpha 1 tubulin and collagen-V, costimulatory molecules (costimulatory molecule 80, costimulatory molecule 86), transcription factors (nuclear factor kappa-light-chain-enhancer of activated B cells, hypoxia-inducible factor 1α, Class II Major Histocompatibility Complex Transactivator), and 20S proteasome.

resultsOf the 90 patients included, we identified 5 with grade 3 primary graft dysfunction, 5 without, 15 with respiratory viral infection, 10 with acute rejection, 10 with donor-specific antibodies (DSA), 5 without DSA, and 10 who were stable for exosome isolation. Recipients with grade 3 primary graft dysfunction, respiratory viral infection, acute rejection, and DSA had exosomes containing self-antigens; exosomes from stable recipients did not. Exosomes from recipients with grade 3 primary graft dysfunction, acute rejection, and DSA also demonstrated costimulatory molecule 80, costimulatory molecule 86, major histocompatibility complex class II, transcription factor, and 20S proteasome.

conclusionsTransplanted lungs with grade 3 primary graft dysfunction, symptomatic respiratory viral infection, acute rejection, and immune responses induce exosomes that contain self-antigens, costimulatory molecules, major histocompatibility complex class II, transcription factors, and 20S proteasome. Release of circulating exosomes post-transplant from the aforementioned stress-inducing insults augment immunity and may play an important role in the pathogenesis of bronchiolitis obliterans syndrome.

Indexed as

Acute DiseaseAdultAgedAutoantigensB7 AntigensBiomarkersBronchiolitis ObliteransCase-Control StudiesCell LineExosomesFemaleGraft RejectionHistocompatibility Antigens Class IIHumansLung TransplantationMaleAutoantigensB7 AntigensBiomarkersHistocompatibility Antigens Class IIProteasome Endopeptidase ComplexTranscription Factorsacute rejectioncirculatory exosomesDSAlung transplantnovel mechanismprimary graft dysfunctionrejection

Identifiers

PMID31288367
PMCPMC6625531
OpenAlexW2912928485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.